DEXAMETHASONE SODIUM PHOSPHATE
Dexfenfluramine is a serotonergic agent previously used for weight loss by enhancing satiety. It increases serotonin release and reuptake inhibition. Withdrawn due to cardiac valvulopathy risk. Side effects include pulmonary hypertension and neuropsychiatric effects.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Dexamethasone sodium phosphate is a water‑soluble glucocorticoid ester enabling rapid systemic absorption. It suppresses NF‑κB signalling, reduces inflammatory mediator release, stabilizes cell membranes and alters leukocyte dynamics. Its rapid onset makes it valuable in acute inflammation research.
Benefits and Advantages
Used in acute‑inflammation modelling, rapid‑delivery steroid research, GR‑phosphorylation pathway studies, and endocrine‑suppression assays.
Side Effects and Risks
Risks include metabolic disturbances, immunosuppression, mood changes, hypertension, fluid retention and adrenal suppression. Handle with systemic‑steroid precautions.
Datasheet
| Molecular Formula | C22H28FNa2O8P |
|---|---|
| Molecular Weight | 516.4 g/mol |
| CAS Number | 2392-39-4 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | DEXAMETHASONE SODIUM PHOSPHATE; 2392-39-4; Dexamethasone 21-phosphate disodium salt; Dalalone; Dexadreson |
| IUPAC/Chemical Name | disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
| InChl Key | PLCQGRYPOISRTQ-FCJDYXGNSA-L |
| InChl Code | InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
